Skip to main content
. 2022 May 26;27(9):3904–3912. doi: 10.1038/s41380-022-01615-6

Table 1.

A: Main baseline demographics of matched cohorts comparing BP-CCBs with amlodipine. A: patients with no prior neuropsychiatric diagnosis. B: patients with a prior neuropsychiatric diagnosisa.

A: no prior neuropsychiatric diagnosis B: with prior neuropsychiatric diagnosis
BP-CCB Amlodipine BP-CCB Amlodipine
Cohort size (n) 44,731 44,731 17,896 17,896
Age at index (y, SD) 58.3 (17.5) 58.8 (16.8) 56.2 (17.1) 56.0 (15.7)
Sex (M:F %) 42:58 43:57 38:62 38:62
Race (W,B,O %)b 50,29,21 48,28,24 61,26,13 62,26,12
Blood pressure 136/77 136/77 134/77c 135/79c
Body mass index (SD) 30.1 (6.7) 29.8 (6.7) 30.7 (7.3) 30.4 (7.1)
Prior psychotic disorder (%) 0 0 3 3
Prior affective disorder (%) 0 0 33 33
Prior anxiety disorder (%) 0 0 32 33
Prior substance use disorder (%) 0 0 27 27
Prior sleep disorder (%) 0 0 33 34
Prior delirium (%) 0 0 4 4
Prior dementia (%) 0 0 2 3
Prior movement disorder (%) 0 0 6 6

aFor additional cohort demographics see Supplementary Table 3. For ICD-10 codes see text. In B, percentages add up to more than 100% since a patient may have a diagnosis in more than one category, and also more than one diagnosis within each category.

bW: white. B: black. O: other or not known. SD: standard deviation.

cStandard difference between cohorts for diastolic blood pressure = 0.12.